Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | 1,2-dimethylhydrazine | multiple interactions | ISO | Zfp628 (Mus musculus) | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of ZFP628 mRNA | CTD | PMID:22206623 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Zfp628 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of ZFP628 mRNA | CTD | PMID:24058054 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of ZFP628 mRNA | CTD | PMID:33387578 | 4,4'-sulfonyldiphenol | increases methylation | ISO | Zfp628 (Mus musculus) | 6480464 | bisphenol S results in increased methylation of ZFP628 exon | CTD | PMID:33297965 | aflatoxin B1 | decreases expression | ISO | ZNF628 (Homo sapiens) | 6480464 | Aflatoxin B1 results in decreased expression of ZNF628 mRNA | CTD | PMID:27153756 | arsenous acid | decreases expression | ISO | ZNF628 (Homo sapiens) | 6480464 | Arsenic Trioxide results in decreased expression of ZNF628 mRNA | CTD | PMID:24356939 | benzo[a]pyrene | decreases expression | ISO | Zfp628 (Mus musculus) | 6480464 | Benzo(a)pyrene results in decreased expression of ZFP628 mRNA | CTD | PMID:22228805 and PMID:27195522 | benzo[a]pyrene | affects methylation | ISO | ZNF628 (Homo sapiens) | 6480464 | Benzo(a)pyrene affects the methylation of ZNF628 promoter | CTD | PMID:27901495 | benzo[a]pyrene | multiple interactions | ISO | Zfp628 (Mus musculus) | 6480464 | [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of ZFP628 mRNA | CTD | PMID:27858113 | benzo[a]pyrene | decreases expression | ISO | ZNF628 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in decreased expression of ZNF628 mRNA | CTD | PMID:24356939 | benzo[b]fluoranthene | multiple interactions | ISO | Zfp628 (Mus musculus) | 6480464 | [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of ZFP628 mRNA | CTD | PMID:27858113 | carbon nanotube | decreases expression | ISO | Zfp628 (Mus musculus) | 6480464 | Nanotubes more ... | CTD | PMID:25554681 | chrysene | decreases expression | ISO | Zfp628 (Mus musculus) | 6480464 | chrysene results in decreased expression of ZFP628 mRNA | CTD | PMID:26377693 | chrysene | multiple interactions | ISO | Zfp628 (Mus musculus) | 6480464 | [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of ZFP628 mRNA | CTD | PMID:27858113 | cisplatin | decreases expression | ISO | ZNF628 (Homo sapiens) | 6480464 | Cisplatin results in decreased expression of ZNF628 mRNA | CTD | PMID:27392435 | cyclosporin A | increases expression | ISO | ZNF628 (Homo sapiens) | 6480464 | Cyclosporine results in increased expression of ZNF628 mRNA | CTD | PMID:25562108 | diarsenic trioxide | decreases expression | ISO | ZNF628 (Homo sapiens) | 6480464 | Arsenic Trioxide results in decreased expression of ZNF628 mRNA | CTD | PMID:24356939 | diazinon | decreases expression | ISO | ZNF628 (Homo sapiens) | 6480464 | Diazinon results in decreased expression of ZNF628 mRNA | CTD | PMID:24356939 | dicrotophos | increases expression | ISO | ZNF628 (Homo sapiens) | 6480464 | dicrotophos results in increased expression of ZNF628 mRNA | CTD | PMID:28302478 | dorsomorphin | multiple interactions | ISO | ZNF628 (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZNF628 mRNA | CTD | PMID:27188386 | folic acid | multiple interactions | ISO | Zfp628 (Mus musculus) | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of ZFP628 mRNA | CTD | PMID:22206623 | gamma-hexachlorocyclohexane | decreases expression | ISO | ZNF628 (Homo sapiens) | 6480464 | Hexachlorocyclohexane results in decreased expression of ZNF628 mRNA | CTD | PMID:24356939 | Indeno[1,2,3-cd]pyrene | decreases expression | ISO | Zfp628 (Mus musculus) | 6480464 | indeno(1 more ... | CTD | PMID:26377693 | Licochalcone B | increases expression | ISO | ZNF628 (Homo sapiens) | 6480464 | licochalcone B results in increased expression of ZNF628 mRNA | CTD | PMID:33647349 | ochratoxin A | decreases expression | ISO | ZNF628 (Homo sapiens) | 6480464 | ochratoxin A metabolite results in decreased expression of ZNF628 mRNA and ochratoxin A results in decreased expression of ZNF628 mRNA | CTD | PMID:24356939 | ozone | multiple interactions | ISO | ZNF628 (Homo sapiens) | 6480464 | [Air Pollutants results in increased abundance of Ozone] which affects the expression of ZNF628 mRNA | CTD | PMID:35430440 | perfluorohexanesulfonic acid | decreases expression | ISO | Zfp628 (Mus musculus) | 6480464 | perfluorohexanesulfonic acid results in decreased expression of ZFP628 mRNA | CTD | PMID:37995155 | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | Zfp628 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of ZFP628 mRNA | CTD | PMID:36331819 | propanil | decreases expression | ISO | ZNF628 (Homo sapiens) | 6480464 | Propanil results in decreased expression of ZNF628 mRNA | CTD | PMID:24356939 | resveratrol | multiple interactions | ISO | ZNF628 (Homo sapiens) | 6480464 | [Plant Extracts co-treated with Resveratrol] results in decreased expression of ZNF628 mRNA | CTD | PMID:23557933 | SB 431542 | multiple interactions | ISO | ZNF628 (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZNF628 mRNA | CTD | PMID:27188386 | silicon dioxide | decreases methylation | ISO | ZNF628 (Homo sapiens) | 6480464 | Silicon Dioxide results in decreased methylation of ZNF628 promoter | CTD | PMID:34973136 | sirolimus | decreases expression | ISO | ZNF628 (Homo sapiens) | 6480464 | Sirolimus results in decreased expression of ZNF628 mRNA | CTD | PMID:24356939 | sodium arsenite | decreases expression | ISO | ZNF628 (Homo sapiens) | 6480464 | sodium arsenite results in decreased expression of ZNF628 mRNA | CTD | PMID:34032870 | tetraphene | multiple interactions | ISO | Zfp628 (Mus musculus) | 6480464 | [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of ZFP628 mRNA | CTD | PMID:27858113 | trichloroethene | increases expression | EXP | | 6480464 | Trichloroethylene results in increased expression of ZFP628 mRNA | CTD | PMID:33387578 | tungsten | decreases expression | ISO | Zfp628 (Mus musculus) | 6480464 | Tungsten results in decreased expression of ZFP628 mRNA | CTD | PMID:30912803 | urethane | affects expression | ISO | ZNF628 (Homo sapiens) | 6480464 | Urethane affects the expression of ZNF628 mRNA | CTD | PMID:28818685 | valproic acid | increases methylation | ISO | ZNF628 (Homo sapiens) | 6480464 | Valproic Acid results in increased methylation of ZNF628 gene | CTD | PMID:29154799 | valproic acid | multiple interactions | ISO | ZNF628 (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZNF628 mRNA | CTD | PMID:27188386 | valproic acid | decreases expression | ISO | ZNF628 (Homo sapiens) | 6480464 | Valproic Acid results in decreased expression of ZNF628 mRNA | CTD | PMID:26272509 | valproic acid | decreases expression | ISO | Zfp628 (Mus musculus) | 6480464 | Valproic Acid results in decreased expression of ZFP628 mRNA | CTD | PMID:19136453 and PMID:21427059 | vinclozolin | affects expression | EXP | | 6480464 | vinclozolin affects the expression of ZFP628 mRNA | CTD | PMID:19015723 | | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
 |
Welcome {{ username}}
Message Center
{{ messageCount }} Messages
Watched Genes
{{$index + 1}}. {{ watchedObject.symbol }} (RGD ID:{{watchedObject.rgdId}})
Watched Ontology Terms
{{gene.symbol}}: {{ gene.description }}
|
| You must be logged in to use this feature |
| {{ loginError }} |
|
|
Analyze GeneStrainQTL List |
 Gene Annotator (Functional Annotation) unavailable |
 Gene Annotator (Annotation Distribution) unavailable |
 Variant Visualizer (Genomic Variants) unavailble Variant Visualizer (Genomic Variants) unavailable |
Gene Annotator (Functional Annotation) |
Gene Annotator (Annotation Distribution) |
Variant Visualizer (Genomic Variants) |
 InterViewer (Protein-Protein Interactions) unavailable |
 Gviewer (Genome Viewer) unavailable |
 Variant Visualizer (Damaging Variants) unavailble Variant Visualizer (Damaging Variants) unavailable |
InterViewer (Protein-Protein Interactions) |
GViewer (Genome Viewer) |
Variant Visualizer (Damaging Variants) |
 Gene Annotator (Annotation Comparison) unavailable |
 OLGA (Gene List Generator) unavailable |
 |
Gene Annotator (Annotation Comparison) |
OLGA (Gene List Generator) |
Excel (Download) |
 MOET (Multi-Ontology Enrichement) unavailable |
 GOLF (Gene-Ortholog Location Finder) unavailable |
|
MOET (Multi-Ontology Enrichement) |
GOLF (Gene-Ortholog Location Finder) |
|
||||||||||
Gene Ontology Annotations Click to see Annotation Detail View
Biological Process
Cellular Component
Molecular Function
